Smith & Nephew plc vs Weibo Corp — how do they compare? Smith & Nephew plc trades at $30.05 (market cap $12.54B), while Weibo Corp trades at $7.77 (market cap $1.93B). The key difference: Smith & Nephew plc is far larger — about 6.5× Weibo Corp's market cap, and Weibo Corp pays the higher dividend (7.75%). Which is the better fit depends on your goals.
| SNN | WB | |
|---|---|---|
Market Cap | $12.54B | $1.93B |
Sector | Health | Media |
52-Week High | $38.70 | $12.83 |
52-Week Low | $28.73 | $7.20 |
Enterprise Value | $15.57B | $1.20B |
Dividend Yield | 2.65% | 7.75% |
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →